financetom
EVE
financetom
/
Financials
/
EVE
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
EVe Mobility Acquisition CorpEVE
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

EVe Mobility Acquisition Corp does not have significant operations.

The company focuses on effectuating a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses.

It intends to focus on the automotive and mobility industry. The company was incorporated in 2021 and is based in Wilmington, Delaware.

Latest News >
--Medpace Guides For 2024 GAAP EPS of $11.71-$12.09 on Revenue of $2.09-$2.13 Billion, vs CIQ Analyst Consensus of $11.56/Share on Revenue of $2.14 Billion
--Medpace Guides For 2024 GAAP EPS of $11.71-$12.09 on Revenue of $2.09-$2.13 Billion, vs CIQ Analyst Consensus of $11.56/Share on Revenue of $2.14 Billion
Oct 22, 2024
04:17 PM EDT, 10/21/2024 (MT Newswires) -- Price: 326.64, Change: -26.28, Percent Change: -7.45 ...
InterContinental Hotels Group's Q3 Global Revenue per Available Room Increases
InterContinental Hotels Group's Q3 Global Revenue per Available Room Increases
Oct 22, 2024
06:27 AM EDT, 10/22/2024 (MT Newswires) -- InterContinental Hotels Group ( IHG ) reported Tuesday a 1.5% increase in Q3 global revenue per available room compared with the same period last year. The Americas saw a 1.7% sales increase, while the EMEA region increased by 4.9%, driven by continued growth in the US. Greater China reported a 10.3% decline due...
US FDA declines to approve Camurus' rare hormone disorder drug
US FDA declines to approve Camurus' rare hormone disorder drug
Oct 22, 2024
Oct 22 (Reuters) - The U.S. Food and Drug Administration has declined to approve Camurus' drug for the treatment of a rare hormonal disorder due to deficiencies at a third-party manufacturing facility, the Swedish drugmaker said late Monday. WHY IT'S IMPORTANT The FDA's decision could delay the approval and subsequent launch of the drug, CAM2029, meant to treat patients with...
FOCUS-Three Mile Island nuclear plant gears up for Big Tech reboot
FOCUS-Three Mile Island nuclear plant gears up for Big Tech reboot
Oct 22, 2024
* Restart work is expected to begin in Q1 2025 * Constellation has ordered major equipment * Microsoft ( MSFT ) would consider similar contracts to restart nuclear power plants * Work includes refurbishing cooling towers and millions of feet of scaffolding * Activists say they will challenge licensing for the plant By Laila Kearney THREE MILE ISLAND, Pennsylvania, Oct...
Copyright 2023-2026 - www.financetom.com All Rights Reserved